(Q35544527)

8 August 2017

1 reference

title

Current topics: brain penetrating neurotensin analog (English)

1 reference

8 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511764

14 March 2024

Mona Boules

1 reference

8 August 2017

Paul Fredrickson

series ordinal

1 reference

8 August 2017

Elliott Richelson

series ordinal

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

17 October 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511764

full work available at URL

14 March 2024

https://api.elsevier.com/content/article/PII:S002432050300674X?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

https://api.elsevier.com/content/article/PII:S002432050300674X?httpAccept=text/plain

14 March 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

14 March 2024

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

2785-2792

1 reference

Hypothermia and intolerance to cold induced by intracisternal administration of the hypothalamic peptide neurotensin

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

A novel neurotensin peptide analog given extracranially decreases food intake and weight in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

A novel neurotensin analog blocks cocaine- and D-amphetamine-induced hyperactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The effects of nicotine on locomotor activity in non-tolerant and tolerant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin: Antinocisponsive action in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Anorectic effect of calcitonin, neurotensin and bombesin infused in the area of the rostral part of the nucleus of the tractus solitarius in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin blocks certain amphetamine-induced behaviours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The DARPP-32 knockout mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Response by the neurotensin systems of the basal ganglia to cocaine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Central nervous system neurotensin and feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Differential neurobehavioral effects of neurotensin and structural analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The neurobiology of neurotensin: focus on neurotensin-dopamine interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin analog NT69L induces rapid and prolonged hypothermia after hypoxic ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Does neurotensin mediate the effects of antipsychotic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin: specific binding to synaptic membranes from rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Functional and pharmacological aspects of central neuropeptidergic transmission mediated by neurotensin and neuromedin n.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The neurotensin receptor: is there more than one subtype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effect of centrally administered neurotensin on multiple feeding paradigms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The effect of neurotensin on food consumption in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The effects of neurotensin on anterior pituitary hormone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin analogs indications for use as potential antipsychotic compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Once weekly administration of nicotine produces long-lasting locomotor sensitization in rats via a nicotinic receptor-mediated mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

CCK and other peptides modulate hypothalamic norepinephrine release in the rat: dependence on hunger or satiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin-induced hypothermia: evidence for an interaction with dopaminergic systems and the hypothalamic--pituitary--thyroid axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Interactions of neurotensin with brain dopamine systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Chronic cocaine administration and withdrawal of cocaine modify neurotensin binding in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Interaction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. The paraventricular CRF neuron as a critical site of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effects of peripheral neurotensin on behavior of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The effect of thyroid hormones in vitro and in vivo on hypothalamic neurotensin release and content

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin: effects of hypothalamic and intravenous injections on eating and drinking in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Extensive co-localization of neurotensin with dopamine in rat meso-cortico-frontal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin: peptide for the next millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Highly potent neurotensin analog that causes hypothermia and antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Parkinson's disease: depletion of substantia nigra neurotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Neurotensin and neurotensin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Increased glucose production following neurotensin administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Heterogeneity of melanized neurons expressing neurotensin receptor messenger RNA in the substantia nigra and the nucleus paranigralis of control and Parkinson's disease brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2803%2900674-X

Effects of prolonged administration of neurotensin, arginine-vasopressin, NPY, and bombesin on blood TSH, T3 and T4 levels in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

Neurotensin: perchance an endogenous neuroleptic?

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

Interactions of neurotensin with brain dopamine systems: biochemical and behavioral studies

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

Persistence of neurochemical changes in dopamine systems after repeated cocaine administration

14 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0024-3205(03)00674-X

14 March 2024

Identifiers

DOI

1 reference

8 August 2017

1 reference